Last reviewed · How we verify
Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid
This study was designed to be a retrospective, multicentre, observational study to evaluate the efficacy and safety of dupilumab in the treatment of bullous pemphigoid and to find predictors of efficacy.
Details
| Lead sponsor | Peking University First Hospital |
|---|---|
| Status | COMPLETED |
| Enrolment | 146 |
| Start date | Thu Sep 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Bullous Pemphigoid
Interventions
- Dupilumab
Countries
China